Clinical trial
Efficacy and Safety of Transdermal Methylphenidate for Cancer-Related Fatigue
NCT01124500 is registered in ClinicalTrials.gov with Memorial Sloan Kettering Cancer Center as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Efficacy and Safety of Transdermal Methylphenidate for Cancer-Related Fatigue
- Lead sponsor
- Memorial Sloan Kettering Cancer Center
- Phase
- Not applicable
- Overall status
- Withdrawn
- Start date
- May 31, 2010
- Completion date
- May 31, 2012
- Enrollment
- 0 (actual)
- Sites
- Not reported
Conditions
As the registry lists them; a condition with its own page is linked.
head and neck cancer